Analysis of clinically relevant mutations revealed an epidermal growth factor receptor (EGFR) mutation for the donor of LCSCs_a as well as tumor tissue of the donor of LCSCs_c showed mutations in the genes for the KRAS proto-oncogene (KRAS) and serine/threonine kinase 11 (STK11). The gene discussed is KRAS; the disease is neoplasm.